Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. A needle-free delivery device can deliver the drug either actively or passively is a rational alternative. Needle free drug delivery technology provides effective drug delivery for wide range of drugs; it is bioequivalent to syringe and needle and results in less pain. In the case of delivering the drug actively, a driving force is necessary for the transport of drug across the skin, which may be accomplished using jet injectors, electroporation, iontophoresis, ultrasound, powder injection, and tape stripping. Different delivery systems have been developed to deliver vaccine to the epidermal layer of skin.
The global needle free drug delivery devices market segmentation is based on technology (jet injectors, novel needle-free technology, transdermal patch technology), and its applications (diabetes, paediatrics, pain management, vaccination). The global needle free drug delivery devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global needle free drug delivery devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global needle free drug delivery devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global needle free drug delivery devices market and included in this report are Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, 3M, Pharmajet, and Zogenix, Inc.